1. Homepagina
  2. Aandelen
  3. China
  4. Shenzhen Stock Exchange
  5. Hangzhou Tigermed Consulting Co., Ltd
  6. Nieuws
  7. Persberichten
    300347   CNE100001KV8

HANGZHOU TIGERMED CONSULTING CO., LTD

(300347)
  Rapport
slotkoers Shenzhen Stock Exchange  -  24-06-2022
104.46 CNY   +6.58%
25/05Hangzhou Tigermed Consulting Co, Ltd kondigt aan dat het definitieve winstuitkeringsplan voor 2021 zal worden uitgevoerd (A-aandelen), uit te betalen op 31 mei 2022
CI
20/05Hangzhou Tigermed Consulting Co., Ltd keurt slotdividend goed voor het jaar dat eindigt op 31 december 2021
CI
28/04Hangzhou Tigermed Consulting Co. Ltd. kondigt gewoon slotdividend aan voor het jaar dat eindigt op 31 december 2021, betaalbaar op 20 juni 2022
CI
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningen 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Communiquťs de presse de la sociťtť HANGZHOU TIGERMED CONSULTING CO., LTD
2021HANGZHOU TIGERMED CONSULTING : 2020 Tigermed Sustainability Report And Environmental, Soci..
PU
2021HANGZHOU TIGERMED CONSULTING : Form of Proxy for the 2021 First H Share Class Meeting to b..
PU
2021HANGZHOU TIGERMED CONSULTING : Notice of the 2021 first h share class meeting
PU
2021HANGZHOU TIGERMED CONSULTING : Form of Proxy for the 2020 Annual General Meeting to be hel..
PU
2021HANGZHOU TIGERMED CONSULTING : (1) proposed partial repurchase and cancellation of the 201..
PU
2021HANGZHOU TIGERMED CONSULTING : Poll voting results of the 2021 second extraordinary genera..
PU
2021HANGZHOU TIGERMED CONSULTING : Notification Letter and Request Form to Non-Registered Hold..
PU
2021HANGZHOU TIGERMED CONSULTING : Form of proxy for the 2021 Second Extraordinary General Mee..
PU
2021HANGZHOU TIGERMED CONSULTING : Notice of the 2021 second extraordinary general meeting
PU
2021HANGZHOU TIGERMED CONSULTING : Proposed adoption of the subsidiary share option scheme; an..
PU
2021HANGZHOU TIGERMED CONSULTING : Announcement - book closure period for 2021 second extraord..
PU
2020HANGZHOU TIGERMED CONSULTING : Full exercise of the over-allotment option, stabilizing act..
PU
2020HANGZHOU TIGERMED CONSULTING : (1) proposed partial repurchase and cancellation of the 201..
PU
2020HANGZHOU TIGERMED CONSULTING : 2019 Sustainability Report
PU
2020HANGZHOU TIGERMED CONSULTING : Terms of reference for the strategy development committee o..
PU
2020HANGZHOU TIGERMED CONSULTING : Terms of reference of the nomination committee of the board..
PU
2020HANGZHOU TIGERMED CONSULTING : Terms of reference of the remuneration and evaluation commi..
PU
2020HANGZHOU TIGERMED CONSULTING : Terms of reference of the audit committee of the board of d..
PU
2020HANGZHOU TIGERMED CONSULTING : Articles of association
PU
2020HANGZHOU TIGERMED CONSULTING : Tigermed Lauded by Frost & Sullivan for Its Rapid, Large-Sc..
AQ
2016MACROSTAT : Receives 2016 Lilly Global Supplier Award
BU
Volgende evenement op HANGZHOU TIGERMED CONSULTING CO., LTD